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births brings the success and worldwide expansion
of the technique towards routine clinical practice."
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Abstract
This paper describes the success and expansion of ovarian tissue
cryopreservation and transplantation as a fertility restoration procedure, with the
largest series of 60 live births worldwide reported. By repeating the procedure,
ovarian activity can be restored for more than 11 years.
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Abstract This paper describes the success and expansion of
ovarian tissue cryopreservation and transplantation as a fertil-
ity restoration procedure, with the largest series of 60 live
births worldwide reported. By repeating the procedure, ovar-
ian activity can be restored for more than 11 years.
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Introduction
Fertility preservation (FP) in young women will be a major
challenge over the next 5 years, in the context of treating
cancer or benign diseases or for social reasons [1].
Unfortunately, only small fractions of patients at risk of
premature ovarian failure (POF) are referred to fertility
preservation specialists to discuss the different options of
FP.
Mature oocyte cryopreservation
Embryo and mature oocyte cryopreservation are the only
methods endorsed by ASRM.
MII oocyte vitrification represents the ideal fertility preser-
vation option in case of benign diseases, social reasons, and
even in cancer women if they are post-pubertal and if chemo-
therapy could be delayed.
Studies of oocyte vitrification in egg donation programs
demonstrated very high oocyte survival rates (92.52 %) and
ongoing pregnancy rates (as high as 43.7%) [2]. Nevertheless,
patients should be aware that around 20 vitrified oocytes are
required to achieve a live birth.
Indeed, in the most experienced teams of the world, the live
birth rate per vitrified oocyte is 5–7 % in egg donation pro-
gram but these results cannot be extrapolated to cancer
women.
Ovarian tissue cryopreservation (OTC)
For prepubertal girls and women who cannot delay the start of
chemotherapy, OTC is the only FP option available [1, 3].
It has also been demonstrated in some series [1] that OTC
during childhood was feasible and safe [1, 4]. Nevertheless, in
that case, left oophorectomy should be performed because of
the small size of the ovaries.
Otherwise, in adults, 4–5 ovarian cortical biopsies (1 cm L,
0.5 mm W, 1.5 mm T) are usually taken.
There are essentially two techniques of orthotopic reim-
plantation (that means Bin the pelvic cavity^) [1]:
1. If at least one ovary is present, pieces of thawed ovarian are
either fixed on the decorticated medulla [1] or pushed by a
small cortical incision under the cortical capsula [5, 6].
Capsule Ovarian tissue transplantation restores ovarian secretion and
allow natural conception.
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2. If the ovary is absent, the ovarian pieces could be placed
in a peritoneal window [7, 8].
The advantages of orthotopic ovarian tissue reimplantation
are the possibility of natural conception (with demonstrated
restoration of fertility) and the favorable environment for fol-
licular development (oxygenation, pressure, presence of peri-
toneal fluid).
Outcomes
1. Restoration of ovarian activity
Restoration of ovarian activity was 100 % if primordial
follicles are present. In a first series, three cases had no folli-
cles in their grafted tissue and of course no restoration of
activity was detected. It highlights the importance of an
Bintact^ follicular density [9].
The mean duration of ovarian function after transplantation
is more or less 5 years in case of high follicular density which
is age dependent.
Data from a series of five women who underwent
ovarian tissue cryopreservation before the age of
22 years (median 19 years) and before any kind of
chemotherapy (Fig. 1) demonstrated that the duration
of ovarian activity restoration was more than 5 years
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Fig. 1 Data from a series of five women who underwent ovarian tissue
cryopreservation before the age of 22 years (median 19 years) and before
any kind of chemotherapy. Case 1—second orthotopic transplantation at
5 years (still functioning after 11 years), case 2—three pregnancies and
deliveries (still functioning after 7 years), case 3—second orthotopic
transplantation at 2 years; 1 pregnancy (egg donation) and delivery,
case 4—two pregnancies and deliveries (still functioning after 5 years),
and case 5—graft still functioning after 5 years
Table 1 Series of 60 live births after transplantation of frozen-thawed ovarian cortex
Cryopreservation
procedure
Number of transplanted
women desiring pregnancy
Number of live births
(..)=ongoing pregnancies
Donnez and Dolmans et al. SF 19 8 (+1)
Meirow et al. SF NA 6
Demeestere et al. SF NA 3
Andersen’s et al. SF 25 8
Silber et al. SF 6 4
Piver et al. and Roux et al. SF NA 3 (+1)
Pellicer et al. SF 33 6a (+3)
Revel et al. SF NA 2
Dittrich et al. SF 20 6
Revelli et al. SF NA 1
Callejo et al. SF NA 1
Stern, Gook, and Rozen SF 14 3a
Kawamura and Suzuki et al. VF NA 2
Burmeister and Kovacs, et al. SF 2 1
Rodriguez-Wallberg and Hovatta et al. SF NA 1
Tanbo et al. SF 2 2
Agarwal et al.b SF NA 1
Makolkin et al., and Kalugina et al.b SF NA 2
Adapted from Fertil Steril [9], the Lancet [10], from two correspondences to the Lancet by Rozen et al. [16], byAndersen [11], and from two publications
by Rodriguez-Wallberg et al. [17] and by Tanbo [18]
SF slow freezing, VF vitrification
a Twins
b Personal communication
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and that by repeating the procedure, ovarian activity can
be restored for more than 11 years. These encouraging
results on ovarian function restoration now lead us to
speculate that in the future, ovarian cortex cryopreserva-
tion at a young age, followed by reimplantation at men-
opause, could be an alternative to hormonal replacement
therapy.
2. Live birth
So far, 60 live births were reported either in peer reviewed
journals or in abstracts of congress (Table 1). All of them but
two were obtained when the slow freezing technique was
applied.
As the number of transplantations (the denominator) is not
known, results for three centers (Denmark, Spain, Belgium)
were collected in a large series [9], and 2 years later in the
largest series taking into account a fourth center (Germany)
[10]. The number of women who conceived is 25 %.
Importantly, at least, two women delivered each three babies
proving the long-term efficacy of the technique in terms of
fertility [10, 11].
Combined technique
(a) OTCmight be combined with the removal of small antral
follicles (by puncture) including those present in the dis-
section medium (Fig. 2). The first pregnancy and live
birth resulting from cryopreserved embryos obtained
from in vitro matured oocytes after oophorectomy in an
ovarian cancer patient was recently published by Prasath
et al. [12], followed by a second live birth reported by
Segers et al. at the Brussels meeting [13].
(b) OTC could be performed between days 0 and 3 of con-
trolled ovarian stimulation (COS) and then, by continu-
ing COS, ovum pick-up with a view of vitrifying oocytes
could increase the efficacy of the fertility preservation. It
was indeed recently demonstrated that the number of
oocytes obtained after COS, following immediately
OTC, was similar to a control group of the same age [14].
Conclusion
Only a small fraction of patients at risk of POF is referred to
specialists to discuss fertility preservation options; of this
group, only a few women actually undergo fertility preserva-
tion owing to social, economic, or technical hurdles. In addi-
tion, women are increasingly postponing childbearing to later
in life for social reasons, and the incidence of most cancers
increases with age.
Health-care providers, particularly the oncologists and he-
matologists, should address the possibility of infertility in pa-
tients requiring gonadotoxic drugs and/or irradiation [15].
They should advise them as to available methods of FP,
referring them to appropriate reproduction specialists. All pa-
tients should receive correct information based on evidence in
terms of fertility, and it is time not to consider anymore ovar-
ian tissue cryopreservation and reimplantation as an experi-
mental procedure.
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